.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Daiichi Sankyo
Harvard Business School
Federal Trade Commission
Cerilliant
Dow
Express Scripts
Julphar
Cipla
QuintilesIMS

Generated: February 21, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: ertapenem sodium

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Merck Sharp DohmeINVANZertapenem sodiumINJECTABLE;INTRAMUSCULAR, IV (INFUSION)021337NDAMerck Sharp & Dohme Corp.N0006-3843-71
Merck Sharp DohmeINVANZertapenem sodiumINJECTABLE;INTRAMUSCULAR, IV (INFUSION)021337NDAMerck Sharp & Dohme Corp.N0006-3845-71
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
McKesson
Medtronic
Argus Health
Daiichi Sankyo
Julphar
Chinese Patent Office
Merck
Novartis
Mallinckrodt

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot